MedTrace Logo

The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of Dreams

NCT02792140 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2017-04-05

No results posted yet for this study

Summary

In this study, the investigators pose the question which influence the opioid circuit has on positive valent situations in dreams.

Conditions

  • Neuroscience of Dreaming, Healthy

Interventions

DRUG

Naltrexone

one week

OTHER

Placebo

one week

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • University of Bern

    lead OTHER

Principal Investigators

  • Fred Mast, Prof. Dr. phil. · Head of Cognitive Psychology, Perception and Research Methods, Dean Human Sciences Faculty, Ordinarius, University of Bern

  • Claudio L. Bassetti, Prof. Dr. med. · Chairman and Head, Department of Neurology Inselspital, Bern University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02792140 on ClinicalTrials.gov